Bexell lab For a complete list of publications, please visit our Lund University Research Portal page (linked on the right hand side).Selected publicationsKarlsson J, Yasui H, Mañas A, Andersson N, Hansson K, Aaltonen K, Jansson C, Durand G, Ravi N, Ferro M, Yang M, Chattopadhyay S, Paulsson K, Spierings D, Foijer F, Valind A, Bexell D, Gisselsson D. (2024) Early evolutionary branching across spat

https://www.tcr.lu.se/research-groups/molecular-pediatric-oncology/publications - 2025-04-29

Team members Sofia Tsalkitzidou Student Julia Wahldén Student Matilda Engström MD Dora Adamic PhD student Hanna Chahin MD, PhD student Alexandra Seger PhD student Aleksandra Adamska Post-doc Erick Muciño Olmos Post-doc Joachim Tetteh Siaw Postdoc Chiara Lago Post-doc Kristina Aaltonen Associate researcher Javan Esfandyari Research engineer Caroline Jansson Lab technician Katarina Turesson Research

https://www.tcr.lu.se/research-groups/molecular-pediatric-oncology/bexell-lab - 2025-04-29

The Bexell lab is grateful for the generous funding from: The European Research CouncilThe Swedish Research CouncilThe Swedish Childhood Cancer FoundationThe Swedish Cancer SocietyThe Medical Faculty at Lund UniversityALF goverment fundingThe Crafoord FoundationÅke Wiberg FoundationThe Royal Physiographic Society in LundBerth von Kantzow Foundation Research portal Visit the Molecular Pediatric Onc

https://www.tcr.lu.se/research-groups/molecular-pediatric-oncology/funding-support - 2025-04-29

We are dedicated to help children with cancer and our work is focused on neuroblastoma, a cancer derived from the sympathetic nervous system. Our overall goals are to investigate mechanisms of metastasis and treatment resistance, and to identify and test novel therapies against high-risk neuroblastoma. We have three main aims: 1. DEVELOPMENT OF CLINICALLY RELEVANT CANCER MODELSClinically relevant

https://www.tcr.lu.se/research-groups/molecular-pediatric-oncology/research - 2025-04-29

In excess of our standard lab equipment we have some specialised machines for certain tests or imaging. IVIS-CTIn Vivo Imaging System Spectrum CT 3D The IVIS Spectrum CT enables longitudinal workflows to characterize disease progression and therapeutic effect in animals throughout the complete experimental time frame with both quantitative CT and optical reconstructions. The preclinical models inc

https://www.tcr.lu.se/equipment - 2025-04-29

In Vivo Imaging System Spectrum CT 3D The IVIS Spectrum CT enables longitudinal workflows to characterize disease progression and therapeutic effect in animals throughout the complete experimental time frame with both quantitative CT and optical reconstructions. The preclinical models includes oncology, toxicology, cardiovascular disease, neurological disorders, inflammation and other related dise

https://www.tcr.lu.se/equipment/ivis-ct - 2025-04-29

PI Håkan Axelson Background Renal cell carcinomas (RCCs) are derived from the epithelial cells of the nephron. Although surgical resection of localized RCC is often curative, treatment of metastasized disease is very challenging as these tumors are virtually resistant to conventional radio- and chemotherapy.  During the last 20 years the genetic landscape of these tumors has been detailed. In para

https://www.tcr.lu.se/research-groups/kidney-cancer-research-group - 2025-04-29

Preclinical Multispectral Optoacoustic Tomography Multispectral Optoacoustic Tomography is a powerful optoacoustic imaging system for small animal imaging. It acquires cross-sectional images from head to tail, with high resolution, in vivo and in real time. The machine is also equipped with ultrasound computed tomography for further insights. MSOT InVision 512-Echo Image rate: 10/2 fps (MSOT/US) S

https://www.tcr.lu.se/equipment/msot - 2025-04-29

Live Cell Inverted Confocal Microscope The Zeiss 710 confocal laser scanning microscopes scan samples sequentially point by point. The microscope combines high-resolution optical imaging with depth selectivity which allows us to do optical sectioning. The inverted microscope is equipped with motorized stage, heated incubator, controller regulating O2, CO2 and humidity. This allow longitudinal imag

https://www.tcr.lu.se/equipment/zeiss-710 - 2025-04-29

We are continuesly working on the accessibility of this webpage. This document describes how well tcr.lu.se complies with the accessibility regulations, any known accessibility issues, and how you can report problems so that we can fix them. If you experience any issues visiting our site we ask that you please contact us and let us know: johanna.verngren@med.lu.se How accessible is tcr.lu.se?This

https://www.tcr.lu.se/accessibility-report - 2025-04-29

PI Johan Staaf Breast Cancer researchBreast cancer is the most common malignancy in women and a heterogeneous disease at the molecular level. This heterogeneity translates into differences in clinical manifestation, patient therapies, and ultimately patient outcome. TNBC is a subgroup of breast cancer, representing ~10% of all cases (9% in Sweden 2015). To date, this patient subgroup has often had

https://www.tcr.lu.se/research-groups/breastlung-cancer - 2025-04-29

Our task is to understand the basic mechanisms behind tumor development. This understanding provides a basis for matching the right drug with the right patient and thereby offer better conditions for individualized treatment of cancer patients. The Division of Translational Cancer Research (TCR) was founded 2013 in conjunction with the formation of Lund University Cancer Center (LUCC) at Medicon V

https://www.tcr.lu.se/translational-cancer-research - 2025-04-29

PI Yvonne Ceder Our researchOur research aims to deduce the role of microRNAs in prostate cancer initiation and progression. The focus of our research is on the miRNA regulation of the transient processes leading to tumor progression and metastases as the reversibility of this type of regulation present a possible interference option. To capture the dynamic events occurring as the tumour cells tra

https://www.tcr.lu.se/research-groups/medical-molecular-biology - 2025-04-29

1 March 2024 13:15 to 14:00 | Seminar TCR-Onco Friday Seminar Series About the eventLocation:ZoomContact:matteo [dot] bocci [at] med [dot] lu [dot] se Save the event to your calendar

https://www.tcr.lu.se/calendar/seminar-kamila-kaminska - 2025-04-29

8 March 2024 13:15 to 14:00 | Seminar TCR-Onco Friday Seminar Series About the eventLocation:ZoomContact:matteo [dot] bocci [at] med [dot] lu [dot] se Save the event to your calendar

https://www.tcr.lu.se/calendar/seminar-piotr-bialas - 2025-04-29

15 March 2024 13:15 to 14:00 | Seminar TCR-Onco Friday Seminar Series About the eventLocation:ZoomContact:matteo [dot] bocci [at] med [dot] lu [dot] se Save the event to your calendar

https://www.tcr.lu.se/calendar/seminar-par-ola-bendahl - 2025-04-29

22 March 2024 13:15 to 14:00 | Seminar TCR-Onco Friday Seminar Series About the eventLocation:ZoomContact:matteo [dot] bocci [at] med [dot] lu [dot] se Save the event to your calendar

https://www.tcr.lu.se/calendar/seminar-anna-karlsson - 2025-04-29

5 April 2024 13:15 to 14:00 | Seminar TCR-Onco Friday Seminar Series About the eventLocation:ZoomContact:matteo [dot] bocci [at] med [dot] lu [dot] se Save the event to your calendar

https://www.tcr.lu.se/calendar/seminar-emma-haxen-0 - 2025-04-29

12 April 2024 13:15 to 14:00 | Seminar TCR-Onco Friday Seminar Series About the eventLocation:ZoomContact:matteo [dot] bocci [at] med [dot] lu [dot] se Save the event to your calendar

https://www.tcr.lu.se/calendar/seminar-volundur-hafstad-0 - 2025-04-29

19 April 2024 13:15 to 14:00 | Seminar TCR-Onco Friday Seminar Series About the eventLocation:ZoomContact:matteo [dot] bocci [at] med [dot] lu [dot] se Save the event to your calendar

https://www.tcr.lu.se/calendar/seminar-paulina-bolivar - 2025-04-29